Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
申请人:Incyte Corporation
公开号:US08278318B2
公开(公告)日:2012-10-02
The present invention relates to certain spirocyclic compounds that are inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 (11βHSD1), compositions containing the same, and methods of using the same for the treatment of diabetes, obesity and other diseases.
Spirocycles as Inhibitors of 11-beta Hydroxyl Steroid Dehydrogenase Type 1
申请人:INCYTE CORPORATION
公开号:US20150210692A1
公开(公告)日:2015-07-30
The present invention relates to certain spirocyclic compounds that are inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 (11βHSD1), compositions containing the same, and methods of using the same for the treatment of diabetes, obesity and other diseases.